Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

Cited by (263)

Items 101–200 of 263

1. Neurologic, Cognitive, and Behavioral Consequences of Opioid Overdose: a Review
   Justin Sup Hong, María Teresa Cabero Morán, Lisa A. Eaton, Lori M. Grafton · 2019 · Current Physical Medicine and Rehabilitation Reports
2. Prescription opioid misusers exhibit blunted parasympathetic regulation during inhibitory control challenge
   Eric L. Garland, Matthew O. Howard · 2021 · Psychopharmacology
3. Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy
   Yun-Hsuan Chang, Shiou‐Lan Chen, Sheng-Yu Lee, Po See Chen, Tzu‐Yun Wang, I Hui Lee, Kao Chin Chen, Yen Kuang Yang, Jau‐Shyong Hong, Ru‐Band Lu · 2015 · Scientific Reports
4. Transcranial direct current stimulation combined with cognitive training improves decision making and executive functions in opioid use disorder: a triple-blind sham-controlled pilot study
   Serkan Aksu, Ahmet Zihni Soyata, Sercan Şeker, Gözde Akkaya, Yasemin YILMAZ, Tuğba Kafalı, Cüneyt Evren, Gökhan Umut · 2023 · Journal of Addictive Diseases
5. Transdiagnostic features of inflammatory markers and executive function across psychiatric disorders
   Tzu‐Yun Wang, Yun‐Hsuan Chang, Sheng-Yu Lee, Hui Hua Chang, Tsung-Yu Tsai, Huai‐Hsuan Tseng, Shao‐Ming Wang, Po See Chen, Kao Chin Chen, I Hui Lee et al. · 2024 · Journal of Psychiatric Research
6. Mitragynine improves cognitive performance in morphine-withdrawn rats
   Chiek Yi You, Zurina Hassan, Christian P. Müller, Farah Wahida Suhaimi · 2021 · Psychopharmacology
7. Comparison of Working Memory and Executive Function in Patients with Internet Addiction Disorder, Attention Deficit Hyperactivity Disorder, and Normal Individuals
   Ali Reza Shafiee‐Kandjani, Zahra Mohammadzadeh, Shahrokh Amiri, Asghar Arfaie, Parvin Sarbakhsh, Salman Safikhanlou · 2020 · international journal high risk behaviors & addiction
8. Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation
   Javier Ballester, Anne K. Baker, Ilkka Kristian Martikainen, Vincent Koppelmans, Jon-Kar Zubieta, Tiffany Love · 2022 · Translational Psychiatry
9. The Opioid Wars—CON
   Thomas A. Anderson · 2019 · Clinical Journal of Pain
10. Effects of chronic tramadol administration on cognitive flexibility in mice
    Elpidio Attoh-Mensah, Marianne Léger, Gilles Loggia, Thomas Fréret, Chantal Chavoix, Pascale Schumann‐Bard · 2021 · Psychopharmacology
11. Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence
    Elena Psederska, Jasmin Vassileva · 2023 · International Journal of Environmental Research and Public Health
12. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
    Travis M. Scott, Julia Hope Arnsten, James Patrick Olsen, Franchesca Arias, Chinazo O. Cunningham, Mónica Rivera Mindt · 2021 · Addiction Science & Clinical Practice
13. Cognitive impairment in opioid use disorders: Is there a case for use of nootropics?
    Gayatri Bhatia, Ragul Ganesh, Alok Kulkarni · 2023 · Psychiatry Research
14. Small Area Estimation and Hotspot Identification of Opioid Use Disorder among Military Veterans Living in the Southern United States
    David L. Albright, Justin Tyler McDaniel, Stefan G. Kertesz, David Wyatt Seal, Katie Prather, Thomas MacAndrew English, Kirsten Laha‐Walsh · 2019 · Substance Abuse
15. Integrating Cognitive Dysfunction Accommodation Strategies Into Behavioral Interventions for Persons on Medication for Opioid Use Disorder
    Colleen B. Mistler, Christie I. Idiong, Michael M. Copenhaver · 2022 · Frontiers in Public Health
16. Inflammatory, oxidative stress and cognitive functions in patients under maintenance treatment with methadone or buprenorphine and healthy subjects
    Mohammad Arezoomandan, Rahele Zhiani, Jamshid Mehrzad, Alireza Motavalizadehkakhky, Sahar Eshrati, Reza Arezoomandan · 2022 · Journal of Clinical Neuroscience
17. Heroin use and neuropsychological impairments: comparison of intravenous and inhalational use
    Abhishek Ghosh, Alka Shaktan, Ritu Nehra, Debasish Basu, Abhishek Verma, Devender Kumar Rana, Manish Modi, Chirag Kamal Ahuja · 2023 · Psychopharmacology
18. Hot and cold executive functions in pure opioid users undergoing methadone maintenance treatment: Effects of methadone dose, treatment duration, and time between last methadone administration and testing
    Usha Barahmand, Ehsan Tavakolian, A Khazaee, Kourosh Mohammadi · 2016 · Nigerian Journal of Clinical Practice
19. Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review
    Enrique Moraleda Barreno, María Pilar Cáceres Pachón, Oscar Martin Lozano, Pedro Juan Pérez-Moreno, José Andrés Lorca Marín, Fermín Fernández‐Calderón, Carmen Díaz, Jesús Gómez Bujedo · 2020 · Journal of Dual Diagnosis
20. Do Opioid Prescriptions Lead to Fatal Car Crashes?
    Michael Betz, Lauren Eden Jones · 2021 · American Journal of Health Economics
21. Drogas, Trastorno por Uso de Sustancias y Conducción: La intervención de los profesionales que trabajan en adicciones
    Francisco Javier Álvarez, Juan Carlos González-Luque, María Seguí‐Gómez · 2015 · Adicciones
22. Impulsiveness, suicide, and aggression in a sample of patients with disorders of methyl amphetamine use
    Moatazbellah I. Ali, Mahmoud M. Rashad, Nasser M. Alzain, Feras A. Al-Awad, Mohammed A. Alzaharani, Abdulsalam S. Alshamarani, Mohammed S. A. Almuqahwi, Shrief Y. Afifi · 2024 · Journal of Family and Community Medicine
23. Executive Dysfunction in Addiction
    Antonio Verdejo‐García · 2017 · Elsevier eBooks
24. Neurocognitive Disorders in Substance Use Disorders
    Hamed Ekhtiari, Mehran Zare-Bidoky, Antonio Verdejo‐García · 2020 · Springer eBooks
25. An Ageing Methadone Population: A Challenge to Aged Persons’ Mental Health Services?
    Adam Searby, Phil Maude, Ian McGrath · 2015 · Issues in Mental Health Nursing
26. Effects of daily morphine treatment on impulsivity in rats responding under an adjusting stop-signal reaction time task
    David Richard Maguire, Christian Mendiondo, Charles Patrick France · 2018 · Behavioural Pharmacology
27. Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment
    Michael M. Copenhaver, Victoria E. Sanborn, Roman Shrestha, Colleen B. Mistler, Matthew C. Sullivan, John Gunstad · 2021 · Drug and Alcohol Dependence
28. Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment
    Michael M. Copenhaver, Victoria E. Sanborn, Roman Shrestha, Colleen B. Mistler, John Gunstad · 2020 · Journal of Addictive Diseases
29. The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory study
    Suky Martinez, Laura Brandt, Sandra D. Comer, FRANCES RUDNICK LEVIN, Jermaine D. Jones · 2022 · Addiction Neuroscience
30. Social Cognition in Opioid Use Disorder
    Emre Yazgeç, Emre Bora, Seda İngeç, Remzi Oğulcan Çıray, Başak Bağcı, Tunç Alkın · 2023 · Substance Use & Misuse
31. Decision-making, somatic markers and emotion processing in opiate users
    Kathryn Biernacki, Gill Terrett, Skye N. McLennan, Izelle Labuschagne, Phoebe Morton, Peter G. Rendell · 2017 · Psychopharmacology
32. Preconception paternal morphine exposure leads to an impulsive phenotype in male rat progeny
    Maryam Azadi, Parisa Moazen, Joost Wiskerke, Saeed Semnanian, Hossein Azizi · 2021 · Psychopharmacology
33. Substance-Induced Mental Disorders
    Alex Baldacchino, Bhags Sharma · 2020 · Springer eBooks
34. Frontal cortex dysfunction as a target for remediation in opiate use disorder: Role in cognitive dysfunction and disordered reward systems
    Dominic Roberts, Andrew Wolfarth, Connie Sánchez, Alan Lars Pehrson · 2018 · Progress in brain research
35. Mindfulness-Oriented Recovery Enhancement reduces post-traumatic stress via reappraisal among patients with chronic pain and co-occurring opioid misuse
    Anna B. Parisi, Justin Hudak, Brett Froeliger, Eric L. Garland · 2023 · Nature Mental Health
36. Neural Correlates of Metacognition Impairment in Opioid Addiction
    Scott J. Moeller, Sameera K. Abeykoon, Pari Dhayagude, Benjamin Varnas, Jodi J. Weinstein, Greg Perlman, Roberto B. Gil, Stephen M. Fleming, Anissa Abi‐Dargham · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
37. Applying Behavior Change Theories and Qualitative Methods in Substance Misuse Implementation Research: Conceptualizing the Adoption of Breaking Free Online in Real-World Clinical Practice
    Stephanie Dugdale, Sarah Elison, Glyn Davies, Jonathan Ward · 2016 · Qualitative Health Research
38. Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial
    Thomas R. Kosten, Efrat Aharonovich, Narinder Nangia, Abigail Zavod, Sarah C. Akerman, Maria V. Lopez-Bresnahan, Maria A. Sullivan · 2020 · Addictive Behaviors
39. Factors associated with cognitive flexibility in people with opioid-use disorder: a pilot study
    Paul S. Regier, Thais Costa Macedo de Arruda, Laura Šinko, Anne M. Teitelman, Anna Rose Childress · 2024 · Frontiers in Psychiatry
40. Latent profile analysis of data from the brief inventory of neurocognitive impairment (BINI) to develop neuro-cognitive profiles among opioid-dependent patients in drug treatment
    John Gunstad, David J. Disabato, Roman Shrestha, Victoria E. Sanborn, Colleen B. Mistler, Michael M. Copenhaver · 2022 · Journal of Addictive Diseases
41. Compulsivity and Inhibitory Control Deficits in Abstinent Individuals With Heroin Addiction and Their Biological Siblings Compared With Unrelated Healthy Control Participants
    Wan-Sen Yan, Su-Jiao Liu, Dan-Hui Zheng · 2023 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
42. Recomendações para uso de opioides no Brasil: parte I
    Durval Campos Kraychete, José Tadeu Tesseroli de Siqueira, João Batista Santos Garcia · 2013 · Revista Dor
43. Neuropsychological screening as a standard of care during discharge from psychiatric hospitalization: The preliminary psychometrics of the CNS Screen
    Boaz Levy, Selda Celen‐Demirtas, Tinatin Surguladze, Sara Eranio, James M. Ellison · 2014 · Psychiatry Research
44. Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross‐Sectional Comparative Study
    Abhishek Ghosh, Debasish Basu, S. K. Mattoo, Devender Kumar Rana, Fazle Roub · 2020 · American Journal on Addictions
45. A neurocognitive model of the comorbidity of substance use and personality disorders
    Jacob W. Koudys, Anthony Charles Ruocco · 2019 · Elsevier eBooks
46. Initial Opioid Prescriptions Predict Continued Narcotic Use: Analysis of 24,594 Reduction Mammaplasty Patients
    David Merola, Nicholas A. Calotta, Zhen Arthur Lu, Scott David Lifchez, Oluseyi Aliu, Devin Coon · 2019 · Plastic & Reconstructive Surgery
47. Negative affectivity drivers of impulsivity in opioid use disorder
    Jasmin Vassileva, Elena Psederska, James Matthew Bjork · 2025 · Nature Reviews Psychology
48. Neurocognitive Functions After 6-Month Buprenorphine (Naloxone)–Based Opioid Agonist Maintenance Treatment
    Abhishek Ghosh, Alka Shaktan, Ritu Nehra, Abhishek Verma, Devender Kumar Rana, Chirag Kamal Ahuja, Manish Modi, Paramjit Singh, Debasish Basu · 2024 · Journal of Clinical Psychopharmacology
49. ALDH2 Gene: Its Effects on the Neuropsychological Functions in Patients with Opioid Use Disorder Undergoing Methadone Maintenance Treatment
    Po-Wei Lee, Tzu‐Yun Wang, Yun‐Hsuan Chang, Sheng-Yu Lee, Shiou‐Lan Chen, Ze-Cheng Wang, Po See Chen, Chun‐Hsien Chu, San‐Yuan Huang, Nian‐Sheng Tzeng et al. · 2020 · Clinical Psychopharmacology and Neuroscience
50. Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys
    Vanessa Minervini, Charles Patrick France · 2020 · Behavioural Pharmacology
51. The effect of bilateral tDCS over dorsolateral prefrontal cortex on the cognitive abilities of men with opioid use disorder under methadone therapy: A sham-controlled clinical trial
    Hossein Mostafavi, Mohsen Dadashi, Alireza Armani Kia, Davod Ahmadi, Reza Pirzeh, Zakaria Eskandari · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
52. Metabolic and functional substrates of impulsive decision-making in individuals with heroin addiction after prolonged methadone maintenance treatment
    Qian Lv, Miao Zhang, Haifeng Jiang, Yilin Liu, Shaoling Zhao, Xiaomin Xu, Wenlei Zhang, Tianzhen Chen, Hang Su, Jiangtao Zhang et al. · 2023 · NeuroImage
53. Comparing attention, impulsivity, and executive functions between patients with opiate use disorder: Buprenorphine maintenance treatment versus active users, in comparison with healthy controls
    Didem Beşikçi Keleş, Rabia Bilici, Batuhan Ayık, Muhsin Koray Kılıç, Wendy L. Kliewer · 2024 · Indian Journal of Psychiatry
54. Impaired De Novo Fear Conditioning in Opiate-Dependent Outpatients
    Shawnee L. Basden, Scott P. Orr, Michael W. Otto · 2016 · Cognitive Therapy and Research
55. 5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of Gαq/11 in postmortem dorsolateral prefrontal cortex of opiate addicts
    Yuji Odagaki, Masakazu Kinoshita, J. Javier Meana, Luis Felipe Callado, Jesús A. Garcı́a-Sevilla · 2021 · Pharmacological Reports
56. An examination of the consequences of chronic exposure to Mitragyna speciosa during adolescence on learning and memory in adulthood
    David M. Compton, Corina Garcia, Annamaria V. Kamaratos, Brittany G. Johnson, Tegan J. Wedge · 2014 · The Journal of Phytopharmacology
57. “Everything is kind of the same except my mind is with me”: exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction
    Corinne A. Beaugard, Alexander Yale Walley, Maryann Amodeo · 2024 · Harm Reduction Journal
58. The inhibitory control deficit of internet gaming disorder: An Event-Related Potentials(ERPs) study
    Junjian Yu, Mohammad Farris Iman Leong Bin Abdullah, Nor Shuhada Mansor · 2024 · Behavioural Brain Research
59. Impact of preexisting opioid dependence on morbidity, length of stay, and inpatient cost of urological oncological surgery
    Sohrab Arora, Chandler Bronkema, Sami E. Majdalany, Nicholas James Corsi, Ivan Rakic, Austin J. Piontkowski, Akshay Sood, Matthew Davis, Daniele Modonutti, Giacomo Novara et al. · 2023 · World Journal of Urology
60. Regaining control over opioid use? The potential application of auricular transcutaneous vagus nerve stimulation to improve opioid treatment in China
    Lorenza S. Colzato, Julia Elmers, Xiaolei Xu, Qiang Zhou, Bernhard Hommel, Christian Beste · 2023 · Addiction Biology
61. Neurocognitive performance of patients undergoing intravenous versus oral opioid agonist treatment: a prospective multicenter study on three-month treatment effects
    Sunsha Chamakalayil, Rudolf Stohler, Andreas Moldovanyi, Markus Gerber, Serge Brand, Kenneth M. Dürsteler · 2024 · Frontiers in Psychiatry
62. Abhängigkeitspotenzial und andere Risiken von Opioidanalgetika im Alter
    Dirk K. Wolter · 2017 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
63. Training and transfer effects of working memory training in male abstinent long-term heroin users
    Xin Zhao, Lei Wang, Joseph H. R. Maes · 2020 · Addictive Behaviors Reports
64. Chronic Pain, Impulsivity, and Risk for Opioid Misuse
    Divya Ramesh, Heather Evans · 2018 · Topics in Pain Management
65. Prenatal methadone exposure produces functional and molecular alterations in the basolateral amygdala and decreased voluntary ethanol intake in female, but not male offspring
    Meredith E. Gamble, Michelle Montero, Dana N. Silberstein, Terrence Deak, Elena I. Varlinskaya, Marvin Rafael Diaz · 2025 · Frontiers in Behavioral Neuroscience
66. Decomposing decision mechanisms in female substance use disorder: drift diffusion modeling of context-dependent biases in gain and loss processing
    Hao Zhang, Gavin Kader, Huoyin Zhang, H. Vicky Zhao, Wanke Pan, Peng Lei · 2025 · BMC Psychiatry
67. Cancer Pain
    Mellar P. Davis · 2018 · Springer eBooks
68. Cognitive Enhancers: What They Are and How They Are Used in Heroin Addiction
    Wenwen Shen, Disen Mei, Yue Liu, Wenhua Zhou · 2022 · Springer eBooks
69. Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study
    Gurneet Kaur, Ajeet Kumar Sidana, Swarndeep Singh, Aarzoo Gupta · 2023 · Journal of Addiction Medicine
70. Genome-wide analyses reveal shared genetic architecture and novel risk loci between opioid use disorder and general cognitive ability
    Børge Holen, Gleda Kutrolli, Alexey A. Shadrin, Romain Icick, Guy Hindley, Linn Nilsen Rødevand, Kevin Sean O’Connell, Oleksandr Frei, Nadine Parker, Markos Tesfaye et al. · 2023 · Drug and Alcohol Dependence
71. The effects of opium tincture and methadone on the cognitive function of patients with opioid use disorder
    James S.H. Wong, Mohammadali Nikoo, Kiana Kianpoor, Ali Gholami, Majid Jazani, Fatemeh Mohammadian, Neda Y. Lafooraki, Kerry L. Jang, Christian G. Schütz, Shahin Akhondzadeh et al. · 2020 · Personality and Individual Differences
72. Pinpointing Neural Correlates of Attachment in Poly-Drug Use: A Diffusion Tensor Imaging Study
    Jürgen Fuchshuber, ­Human‐Friedrich Unterrainer, Michaela Hiebler‐Ragger, Karl Koschutnig, Ilona Papousek, Elisabeth M. Weiss, Andréas Fink · 2020 · Frontiers in Neuroscience
73. Clinical and Cognitive Effects of Computer Assisted Cognitive Remediation Method in Turkish Men with Opioid Use Disorder: A Randomized Controlled Trial
    Nihal TAŞTEKİN, Başak Ünübol, Medine Yazıcı Güleç · 2022 · Substance Use & Misuse
74. Opioid abuse and labor investment efficiency
    Jing Jia, Zhongtian Li · 2023 · International Review of Economics & Finance
75. Remifentanil maintains lower initial delayed nonmatching-to-sample accuracy compared to food pellets in male rhesus monkeys.
    Blake A. Hutsell, Matthew L. Banks · 2017 · Experimental and Clinical Psychopharmacology
76. The Impact of Opioid Drugs on Memory and Other Cognitive Functions: A Review
    Mason Tate Bennett, Yuliya Modna, Dev Kumar Shah · 2024 · Journal of Biosciences and Medicines
77. Exploring the spectrum of heroin-induced changes in the rat brain
    Proushat Shirvani, Paniz Shirvani, Seyed Mohammadmisagh Moteshakereh, Zahrasadat Lajevardi, Seyedeh Naghmeh Nourirad, Nahal Babaeian Amini, Zahra Niakan, Siavash Parvardeh, Amir‐Hossein Bayat, Ramtin Hajibeygi et al. · 2025 · 3 Biotech
78. Executive Dysfunction Associated with Substance Abuse
    Olga Inozemtseva, Edgar Mejía Núñez · 2019 · Springer eBooks
79. Cognitive Enhancers: What They Are and How They Are Used in Heroin Addiction
    Wen-Wen Shen, Disen Mei, Yue Liu, Wenhua Zhou · 2022 · Handbook of Substance Misuse and Addictions
80. Case Report: De Novo and Persistent Psychosis After Withdrawal From Chronic Opioid Therapy
    Brittany N. Goldstein, Xavier F. Jimenez · 2022 · Journal of Psychiatric Practice
81. Quality of Life and Opioid Use Motives: Direct and Indirect Associations with Risky Opioid Use in a Community Sample of Adults
    Jennifer D. Earnest, Melissa R. Hatch, Margo C. Hurlocker · 2022 · Substance Use & Misuse
82. The characteristics, mechanisms and interventions of drug addicts' decision-making defects
    Ling Yang, Dongwei YAO, Hua CAO, Binqiang Wang, Yuanyuan He, Hongting Su · 2019 · Advances in Psychological Science
83. Comparison of cognitive functioning in abstinent opiate-dependent individuals, methadone-maintenance patients and healthy controls: study protocol and update of the existing literature
    Michael Soyka, Lynn Peters, Peggy Schmidt, Annina Haberthür · 2013 · Neuropsychiatry
84. The Effect of Chronic Opioid Use on End-Tidal Concentration of Sevoflurane Necessary to Maintain a Bispectral Index Below 50: A Prospective, Single-Blind Study
    Tak Kyu Oh, Woosik Eom, Jiyeon Yim, Namwoo Kim, Kyungho Kwon, Seong-Eun Kim, Dae Hyun Kim · 2017 · Anesthesia & Analgesia
85. Neurologic Effects of Drug Abuse
    Kewal K. Jain · 2021 · Springer eBooks
86. Increased risky choice during forced abstinence from fentanyl on the cued rat gambling task
    Kelly M. Hrelja, Carol Kawkab, Dimitrios K. Avramidis, Shrishti Ramaiah, Catharine A. Winstanley · 2024 · Psychopharmacology
87. Reward Sensitivity in Patients Receiving Opioid Agonist and Antagonist Treatment for Opioid Use Disorder: An Observational Study
    Martin Trøstheim, Mads L. Pedersen, Siri Leknes, Lennja Majid Hama, Mathias Nikolai Roland, Philipp Paul Koren Lobmaier, Kristin Klemmetsby Solli, Bente Margrethe Weimand, Lars Tanum, Marie Eikemo · 2025 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
88. The exercise–irisin–prefrontal cortex axis in regulating social cognition: A new framework for understanding and treating substance use disorders
    Xiaohui Zhai, Dongshi Wang · 2026 · Neuroscience & Biobehavioral Reviews
89. Diversities of behavioral traits and neuropsychological function in different substance addiction
    Hui‐Yi Wang, Tzong‐Shi Wang, Yi-Chyan Chen · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
90. Cognitive functions in opioid-dependent males according to duration of abstinence
    Buket Koparal · 2020 · Dusunen Adam The Journal of Psychiatry and Neurological Sciences
91. Neurocognitive Functions in Patients with Comorbid Hepatitis C and Opioid Dependence: A Comparative Study
    Abhishek Ghosh, Tathagata Mahintamani, Devender Kumar Rana, Debasish Basu, Surendra K. Mattoo, Madhumita Premkumar, Geetesh Kumar Singh · 2022 · Indian Journal of Psychological Medicine
92. Neurocognitive Impairment and HIV Treatment Engagement in Men Who Have Sex With Men Living With HIV Who Report Chronic Pain and Substance Use
    Matthew C. Sullivan, Megan R. Wirtz, Samantha M. McKetchnie, Lauren R. Gulbicki, S. Wade Taylor, Jonathan D. Jampel, Nikhil Banerjee, Conall M. O’Cleirigh · 2025 · AIDS Research and Treatment
93. A Self-report Measure to Detect Neurocognitive Impairment Among Incarcerated People Living with HIV in Malaysian Context: an Exploratory Factor Analysis
    Roman Shrestha, Damian Weikum, Michael Copenhaver, Frederick Lewis Altice · 2017 · International Journal of Mental Health and Addiction
94. Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose
    Allen M. Smith, Mahip Acharya, Teresa J. Hudson, Corey J. Hayes, Austin Porter, Jamie Turpin, Jonathan P. Bona, Joseph Utecht, Bradley C. Martin · 2022 · Journal of the American Pharmacists Association
95. Substance Use Disorders: Cognitive Sequelae, Behavioral Manifestations, Neuroimaging Correlates, and Novel Interventions
    James Joseph Mahoney, Kirk R. Bryant, Marc W. Haut · 2019 · Springer eBooks
96. Cognitive consequences of opioid use
    Alex Baldacchino, J. Douglas Steele, Fleur D. Davey, Serenella Tolomeo · 2019 · Elsevier eBooks
97. Substance-Induced Mental Disorders
    Alex Baldacchino, V. Arvapalli, Anthony Oshun, Serenella Tolomeo · 2014 · Springer eBooks
98. Neurocognitive Functions Among Patients Dependent on Natural Opium: A Comparative Cross-Sectional Study
    Raghvendra S Singh, Navratan Suthar, Mukesh Kumar Swami, Tanu Gupta, Naresh Nebhinani, Dharamveer Yadav · 2025 · Cureus
99. The preoperative risk factors of chronic postsurgical pain: a retrospective cohort study in the UK Biobank
    Tumaresi Batuer, Yundi Hu, Fan Wu, Runye Shi, Haojing Duan, Jiehui Liu, Yanzi Lian, Junjun Yang, Yuwen Zhang, Jingya Zhang et al. · 2025 · International Journal of Surgery
100. Morphological Brain Alterations and Network Disorganizations in Individuals With Substance Use Disorders: Differential Effects of Heroin Versus Methamphetamine
     Xiaoliang Zhou, Wenbin Liang, Man Lou, Jiangpei Zhao · 2025 · Brain and Behavior